Analysis of the functions of AP-1 transcription factor in cellular systems has shown its key role as a mediator of oncogenic signals. The employment of suitable animal model systems greatly facilitates the study of changes in the composition and activity of the AP-1 complex. Here, we have analysed the quantitative and qualitative changes of AP-1 at dierent stages of carcinogenesis in mouse skin cell lines, derived from tumours induced by chemical mutagens. The ®ndings of this study suggest that elevated AP-1 DNA binding and transactivation activity characterize the carcinoma cell lines, most notably the highly malignant spindle carcinomas. In addition, increased amounts and post-translational modi®cations of c-Jun, Fra-1, Fra-2 and ATF-2 proteins account for a high percentage of the increased AP-1 activity. Remarkably, high levels of phosphorylated ATF-2 protein were detected in malignant cell lines, indicating a novel role of ATF-2 in tumour progression. c-Jun and ATF-2 proteins are phosphorylated by highly active JNK kinases present in tumour cells. Finally, our results indicate distinct functions for dierent AP-1 components in the promotion and progression of mouse skin tumours. Oncogene (2000) 19, 4011 ± 4021.
Introduction
In eukaryotic cells, surface stimuli cause a series of intracellular signals that ultimately aect the activities of proteins binding to transcriptional control elements, thus selectively regulating gene expression (for review see Burley, 1994) . A number of these transcription factors form dimeric complexes and in this form they interact with a limited set of de®ned DNA motifs. Very often, protein dimers may have distinct transcriptional properties, although they exhibit similar DNA-binding speci®cities.
Transcription factor AP-1 (activator protein 1) plays an important role in cell proliferation, dierentiation, apoptosis and transformation. It is composed of homo and heterodimeric complexes of Jun, Fos and ATF family members and regulates transcription by interacting with the DNA-regulatory elements. Depending on the composition of the dimer, dierent sequence elements are preferentially recognised. c-Jun/c-Jun homodimers and c-Jun/c-Fos heterodimers bind to the AP-1 consensus sequence TGAC/GTCA (Angel et al., 1987) . ATF-2 homodimers and c-Jun/ATF-2 heterodimers prefer the ATF/CREB consensus sequence TG/TACGTCA (Benbrook and Jones, 1990) . Members of all three families participate at the end of signal transduction pathways, which are initiated at the cell surface in response to cytokines, growth factors, tumour promoters and overexpression of certain oncogenes (Karin et al., 1997) . The jun family comprises of three members (c-jun, junB, and junD) (Bohmann et al., 1987; Hirai et al., 1989; Ryder et al., 1988) and the fos family of four dierent genes (c-fos, fos B, fra-1, fra-2) (Cohen and Curran, 1988; Nishina et al., 1990; Zerial et al., 1989) . Activating transcription factor 2 (ATF-2) is a member of the ATF/CREB bZip family of transcription factors. ATF-2 plays important roles in the early events of signaling pathways, since phosphorylation of this factor by the c-jun-N-terminusassociated kinases increases its transactivating properties and permits the early activation of the c-jun promoter (Van Dam et al., 1995) . The activity of AP-1 is regulated at the level of transcription of jun and fos genes, by protein ± protein interactions and posttranslational modi®cations of Jun and Fos proteins (Pulverer et al., 1991; Gruda et al., 1994; Oehler et al., 1993) .
Mutant Ras proteins can induce proliferation in certain cell types (Feramisco et al., 1984) , but are also capable of inhibiting the growth of ®broblasts (Hirakawa and Ruley, 1988) , and keratinocytes (Quintanilla et al., 1991) and of stimulating dierentiation in vitro (Hankins and Scolnick, 1981) . The p21Ras proteins are frequently mutated in human tumours, and provide a link between receptors at the cell membrane with the cytoplasmic cascade of protein kinases followed by downstream nuclear events, including induction of transcription and DNA synthesis. Oncogenic Ras proteins have been shown to regulate AP-1 activity at transcriptional and posttranslational levels Binetruy et al., 1991; Derijard et al., 1994; Mechta et al., 1997) . Among the jun family genes that encode for transcription factors, only c-jun displays full transforming potential in cooperation with activated H-ras in primary rat embryo ®broblasts (Schutte et al., 1989a) . Phosphorylation of N-terminal c-Jun protein residues Ser-63 and Ser-73 by JNK kinases is necessary for transactivation and oncogene cooperation using in vitro transformation assays. Analysis of the transforming response to ras in cells carrying a homozygous null mutation of the c-jun gene has shown that these cells are markedly impaired both in the AP-1 transcriptional response and in the ability to be transformed by activated Ras proteins (Johnson et al., 1996) . JunB and JunD can also cooperate with Ras to induce foci, but with lower eciency compared to c-Jun (Schutte et al., 1989b; Vandel et al., 1996) . JunD protein has been reported to eciently suppress transformation by an activated ras gene (Pfarr et al., 1994) . Investigation of Fos protein levels has shown that Fra-2 protein plays a crucial role in the transformation induced by H-ras gene in CEF (Susuki et al., 1994) . In addition, Fra-1 protein induces morphological transformation and increases invasiveness and motility of mouse adenocarcinoma cells (Kustikova et al., 1998) .
Animal model systems have been invaluable in the analysis of multistage carcinogenesis and have formed the basis for much of our present understanding of the genetic and biological changes involved in the development of solid tumours. In particular, mouse skin has provided the paradigm for studies of multistage carcinogenesis in rodents (Yuspa and Poirier, 1988) . Carcinogenesis can be initiated in normal epithelial cells by a single treatment of the skin with a variety of chemical mutagens, which have been previously shown to induce carcinogen-speci®c mutations in the H-ras gene (Balmain and Brown, 1988) . Mutations in the Hras gene confer a selective advantage upon initiated cells, which then develop into benign tumours after treatment with promoting agents such as 12-Otetradecanoyl phorbol-13-acetate (TPA).
We have developed a series of cell lines representing dierent stages of mouse skin tumour progression. These include immortalized, non-tumourigenic keratinocyte lines, benign papilloma and squamous carcinoma cell lines, which give rise to well dierentiated tumours upon injection into nude mice. We have also developed highly anaplastic, invasive spindle cell lines, which have been shown to invade in vitro and exhibit extremely aggresive tumour growth, including metastasis in vivo (Buchmann et al., 1991; Quintanilla et al., 1991) . These cell lines are representative for the development of three distinct stages in mouse carcinogenesis including benign papillomas, locally invasive squamous carcinomas and metastatic spindle carcinomas. All the cell lines have been extensively characterized with regard to the status of a number of oncogenes and tumour suppressor genes, including Hras, p53, cyclin D1, Rb and p16 (Quintanilla et al., 1991; Burns et al., 1991; Linardopoulos et al., 1995; and unpublished results) . In addition, two of the cell lines, B9 and A5, that represent the squamous and spindle stages were derived from the same original tumour, and carry identical mutations in both H-ras and p53 genes (Burns et al., 1991) . These cells therefore, allow comparison of the speci®c changes associated with malignant progression.
In the present study, we have chosen cell lines that all, except the control, were obtained from tumours initiated in vivo with DMBA, and consequently carry the H-ras mutation at codon 61, which is typically induced by this initiating agent (Quintanilla et al., 1986) .
We analysed the expression patterns of Jun, Fos and ATF-2 proteins during mouse skin carcinogenesis and we show that phosphorylated forms of c-Jun, Fra-1, Fra-2 and ATF-2 proteins are expressed in higher amounts in the squamous carcinoma cell lines and especially in the metastatic cell lines with spindle morphology. The DNA binding and transactivation properties of AP-1 transcription factor were further investigated and AP-1 activity was found to be elevated in the malignant cell lines, peaking in the fully metastatic cell lines. Our results also suggest for the ®rst time that ATF-2 plays an important role in the progression of mouse skin tumours.
Results

Altered expression of normal and mutant H-ras during mouse tumour progression
Previous work has already identi®ed genetic changes leading to altered ratios of normal and mutant H-ras alleles during tumour progression (Bremner and Balmain, 1990) . Some of these changes involved nondisjunction of the whole of chromosome 7, while others were mitotic recombinations leading to homozygocity at the distal part of this chromosome, which includes the H-ras locus (Kemp et al., 1993) . In the present study, we used four representative cell lines for the speci®c stages of tumourigenesis to demonstrate that the documented genetic alterations leading to changes in the mutant:normal H-ras gene ratios were re¯ected in corresponding changes in the protein expression levels. Figure 1 shows a Western blot analysis of H-ras expression in C5N (lane 1) (which contains only normal H-ras) cells, the epidermal squamous tumour line B9 (lane 2) and the spindle tumour A5 and CarB cell lines (lanes 3 and 4 respectively). The unique pair of B9 and A5 cell lines, represents squamous and undierentiated spindle variant isolated from the same primary tumour (Burns et al., 1991) . The B9 clone has a typical epithelial morphology, expresses cytokeratines as well as the cell adhesion molecule E-cadherin, whereas the A5 clone has an altered cytoskeleton, fails to express E-cadherin and grows with ®broblastic morphology both in vitro and in vivo (Stoler et al., 1993) . Nevertheless, the squamous and spindle clones are derived from a common precursor cell, hence they have exactly the same spectrum of mutations in the Hras gene and in both alleles of the p53 tumour suppressor gene (Burns et al., 1991) . Southern analysis and RNA protection assay has indicated that the mutant allele was substantially increased in expression in the spindle cells (Crombie et al., unpublished results) . Immunoprecipitation of normal and mutant Ras-proteins from cell lysates followed by Western blotting using Ras-speci®c antibodies, further con®rmed these ®ndings. Interestingly, this protein analysis also indicated that the normal H-ras allele was expressed at high levels in the immortalized C5N cells, while in the spindle clone (A5) it was expressed at lower level. The spindle CarB cell line expresses only the mutant form of H-Ras protein.
Increased expression of c-Jun, Fra-1, Fra-2 and ATF-2 proteins in tumourigenic cell lines
The altered expression of normal and mutant H-ras from the initiated state to the fully malignant spindle carcinomas in cell lines and primary tumours, lead us to investigate the role of AP-1 family members in the process of progression of mouse skin cancer.
Puri®ed polyclonal antisera against Jun family members, which have already been characterized (Pfarr et al., 1994; Black et al., 1994) , were used for immunoblotting experiments and the amounts of Jun proteins were analysed. Figure 2A1 shows the amount of c-Jun protein present in nuclear protein extracts prepared from exponentially growing cells, using antic-Jun speci®c antiserum (Pfarr et al., 1994) . The c-Jun protein level was increased in average 2.53-fold in the squamous carcinoma cell line B9 (lane 3), 2.81 in A5 cells (lane 4) and more than 3.8-fold in CarB spindle cell line (lane 5) compared to the C5N immortalized cell line (lane 1). This result was con®rmed by using a second anti-c-Jun speci®c antiserum (Black et al., 1994, data not shown) . The increase in total c-Jun levels is accompanied by an increase of phosphorylated c-Jun at ser 63, as shown by Western blot analysis ( Figure  2A2 ), using speci®c anti-phospho-c-Jun antiserum (Lallemand et al., 1998) .
The levels of the phosphorylated c-Jun were increased in average by 2.62-fold in squamous cell line B9 (lane 3), 5.4-fold in A5 (lane 4) and 6.45-fold in CarB (lane 5) cells, in comparison to the C5N immortalized cell line (lane 1). The levels of phosphoSer63-c-Jun proteins were further analysed in additional mouse keratinocyte cell lines, like the immortalized C5N and the malignant PDV57, D3, SN161 and H11 (for details see Bremner and Balmain, 1990) ( Figure 2A3 ) and were found to be elevated in tumour cells. We therefore concluded that, the high levels of phosphorylated c-Jun correlated with the progression of mouse skin carcinogenesis and with more aggressive phenotypes.
Analysis of the other Jun family members by Western blotting revealed that, whilst the levels of JunD ( Figure 2C ) remained more or less stable in all cell lines, increased JunB levels were found only in the B9 cell line (6.8-fold increase in B9 cells compared to C5N) ( Figure 2B ). This result indicates that JunB overexpression may play a speci®c role in the formation of the squamous carcinoma phenotype.
Expression of Fos family members was tested by using speci®c antisera . The levels of Fra-1 and Fra-2 proteins detected in the immortalized cells C5N were high ( Figure 3A ,B). There are three immunoreactive bands corresponding to Fra-1 on the Western blot and two or three for Fra-2. Treatment of nuclear extracts with alkaline phosphatase resulted in the elimination of the slower migrating Fra-1 band and the appearance of a faster migrating band on the blot, indicating that Fra-1 proteins are phospho-proteins ( Figure 3A2 ). The high levels of hyper-phosphorylated Fra-1 characterize the malignant phenotypes and the progression of carcinogenesis, as found in the B9, A5 and CarB cell lines ( Figure 3A1 ). Changes in the Fra-2 protein levels between the C5N and the other cell lines correlate with the development of papillomas in this particular model, as well as with further progression of carcinogenesis ( Figure 3B ). cFos protein levels were found to be elevated in P1 and B9 cell lines and highly increased in the spindle phenotypes ( Figure 3C ). These results are compatible with the high levels of expression of SRF protein and the ternary complex formation on the c-fos SRE in the A5 and CarB cells (E Psihari, A Balmain and A Pintzas, manuscript in preparation).
ATF-2 protein expression was also analysed in the mouse cell lines. It was observed ( Figure 4A1 and A2), by using speci®c anti-ATF-2 antibodies, that the overexpression of total and phosphorylated ATF-2 at threonines 69 and 71, correlated with malignant phenotypes (B9, A5 and CarB cell lines). The phospho-ATF-2 protein level is increased by 2.8-fold in the papilloma cell line, 7.9-fold in B9 and more than ninefold in A5 cells, compared to the immortalized line, C5N. The highest levels of the phosphorylated ATF-2 were found in the CarB cells, with a 12-fold increase. This result suggests, for the ®rst time, a role for ATF-2 protein in malignant progression of mouse epidermis. Interestingly, the existence of a double band at around 35 kd ( Figure 4A1 lanes 4 and 5), which is characteristic of the spindle phenotypes, may be due either to the presence of dierent splice forms of ATF-2 or to non-speci®c cross reaction of the ATF-2 antibody.
JNK activity is correlated with high levels of phosphorylated forms of c-Jun and ATF-2 proteins in the malignant cell lines
Since Ras-activated members of the JNK subgroup of MAPKs are the major mediators of c-Jun and ATF-2 aminoterminal phosphorylation (Campbell et al., 1998) , JNK protein and activity levels were studied next. Western blot analysis of nuclear extracts showed that the content of JNK1 and JNK2 isoforms was altered in the malignant cell lines ( Figure 5A1 ). When compared to the C5N control cell line (lane 1), JNK1 protein level was increased in average by twofold in the squamous carcinoma cell line B9 (lane 3), and more than eightfold in the clonally related A5 spindle cell line (lane 4). A similar eightfold elevation was detected Oncogene Elevated c-Jun, Fra-2, Fra-1, ATF-2 and AP-1 in skin tumours V Zoumpourlis et al in the independently derived CarB spindle line (lane 5). JNK2 protein level was also increased, but to a more modest level of 2.1-fold and 4.25-fold in B9 and A5 cells respectively.
To extend the validity of these results, we analysed the endogenous in vitro kinase activity of JNK using a GST-c-Jun substrate. The solid phase-kinase assay ( Figure 5A2 ) showed that JNK activity was increased more than threefold in the malignant cell lines (B9, A5 and CarB), in comparison to C5N immortalized and P1 papilloma cell lines. Similar results were obtained by IP-kinase assay (data not shown). Quantitative and The levels of these proteins were determined by speci®c antisera Figure 3 Expression of Fos proteins in mouse cell lines. Equal amounts of NE were loaded in each lane and resolved by electrophoresis on a 10% SDS ± PAGE gel. (A1) Fra-1 protein levels were determined by immunoblot by using speci®c polyclonal antiserum. (A2) Fra-1 protein is a phosphoprotein. Nuclear protein extracts were incubated for 2 h at 378C with (+) or without (7) 20 U of alkaline phosphatase and were immunoblotted with anti-Fra-1 speci®c antiserum. (B) Fra-2 protein levels were determined by speci®c antiserum. (C) Speci®c anti-c-Fos polyclonal antiserum was used to determine the amount of c-Fos protein Elevated c-Jun, Fra-2, Fra-1, ATF-2 and AP-1 in skin tumours V Zoumpourlis et al qualitative changes in the expression levels of JNK isoforms are closely associated with the high levels of phosphorylated c-Jun and ATF-2 in the squamous carcinoma cell line B9 and the A5 and CarB spindle cell lines.
Coll II TRE AP-1 binding and transcriptional activity increases in the papilloma cell line and peaks in the tumourigenic cells. c-Jun, Fra-1 and Fra-2 are the major components of the AP-1 complex in transformed cells
Altered expression and post-translational modi®cations of AP-1 family members were observed in mouse skin cell lines. To examine whether these changes result in changes of AP-1 DNA binding activity, electrophoretic mobility shift assay was performed by using nuclear extracts and 32 P-labelled oligonucleotide containing an AP-1 binding site (TRE, TPA-responsive element) (Garner and Revzin, 1981) . Nuclear extracts were incubated with TRE-containing oligonucleotide from the human collagenase promoter. AP-1 activity was detected to be slightly increased in the P1 papilloma cell line compared to C5N was further elevated in the tumourigenic cell line B9 and peaked in the metastatic A5 and CarB cell lines ( Figure 6A ). Due to the similar MW of the Jun family members, dierent homo-and heterodimeric complexes appear to form a unique complex on the TRE. Quanti®cation of the AP-1-TRE complex showed 2.7-fold increase of AP-1 activity in P1 cells, 4.8-fold in B9 and almost 7.5-fold increase in A5 and CarB cell lines compared to the AP-1 levels in C5N ( Figure 6B ). These results are in agreement with the changes in the abundance and the phosphorylation status of c-Jun, Fra-1, Fra-2 and ATF-2 in the malignant cell lines, which have either only mutated or multiple copies of H-ras gene.
Transformation of cells by oncogenes results in an increased transcriptional activity of the AP-1 transcription factor, mainly through augmentation of c-Jun transcriptional activity (Westwick et al., 1994) . Since we had already detected elevated AP-1 DNA binding activity in transformed cells, we next examined the level of the AP-1 dependent transcriptional activation in the same cell lines. Transient transfections in the corresponding cell lines were performed, by using Luc reporter plasmids with or without the collagenase TRE (TPA-responsive element) (Van Dam et al., 1998) . Luciferase activity was found to be elevated 3-5-fold in all malignant cell lines tested, with highest levels detected in A5 and CarB spindle carcinoma cells ( Figure 6C ). TRE-Luc activity observed in all cell lines compared to C5N cells was: P1: 61.55, B9: 63.67, A5: 64.33, CarB: 65.1. Similar results, showing elevated AP-1 DNA binding and transcriptional activity in malignant cells, were obtained by using the additional immortalized C5N and malignant PDV57, D3 and SN161 cell lines (data not shown).
The composition of AP-1 CollII TRE binding activity was probed by addition of speci®c anti-Jun and anti-Fos antisera prior to the protein-DNA complex formation. As a consequence, we detected a decrease in AP-1 activity, the strength of which depends on the amount of each speci®c component present in the complex. Addition of anti-c-Jun speci®c antibody resulted in a marked decrease of AP-1 activity, indicating that c-Jun protein is the major Jun protein in the complex formed with extracts from the tumourigenic cell lines ( Figure 6C ; lanes 6 ± 10). The contribution of JunB protein in the composition of AP-1 DNA complex was greater in B9 cells compared to A5 and CarB cells, while it was absent in C5N and P1 (data not shown). A small amount of JunD Further analysis of the AP-1 DNA complex showed that in the tumourigenic cell lines, Fra-1 and Fra-2 proteins were the main Jun partners ( Figure 6C ; lanes 3 ± 5 and 13 ± 15 respectively). In the case of c-Fos, it appeared to participate less in the AP-1 DNA complex (data not shown). In conclusion, c-Jun and Fra factors are implicated in tumour progression of mouse skin.
AP-1 Jun2TRE binding and transcriptional activity is elevated in malignant cell lines. ATF-2 is the major component of the complex in the transformed cells
To verify the eect of c-Jun and ATF-2 complexes in all mouse skin cell lines, we used a jun2TRE sequence, which contains an octameric TRE sequence of the mouse c-jun promoter. This sequence is responsive selectively to c-jun/ATF-2 dimers. Analysis by retardation assay ( Figure 7A ), showed elevated c-jun/ATF-2 binding activity in the malignant cell lines (B9, A5 and CarB). The AP-1 jun2TRE binding activity observed in all cell lines, compared to C5N cells, was: P1:x0.95, B9 : 4.3, A5 : 5.25 and CarB: 5.75 ( Figure 7B ).
We also examined the transactivation activity of cJun/ATF-2 heterodimers. All the cell lines were transiently transfected with 5xjun2 TRE-tata-Luciferase or tata-luciferase reporter plasmids (Van Dam et al., 1998) . In this case, the luciferase activity was elevated 4 ± 6-fold in malignant cell lines, compared to C5N cells ( Figure 7D ).
Transfection eciency was normalized by measuring b-gal activity and the average of three independent experiments is presented. The AP-1 transcriptional activity correlated with the total AP-1 DNA binding activity in mouse skin cell lines. Antibody supershift analysis was performed in order to determine the presence of c-Jun and ATF-2 molecules in the AP-1 jun2TRE complexes, detected by EMSA. Nuclear extracts of the immortalized C5N and the transformed mouse skin cell lines (P1, B9, A5 and CarB) were incubated with anti-c-Jun or anti-ATF-2 antisera for 1 h at 48C prior to the addition of the Jun2TRE probe and the formation of protein-DNA complex. As we can see in Figure 7C , high amounts of complexes Gel retardation analysis of NE from immortalized and transformed keratinocytes was performed using a CollII TRE as a probe. Where indicated, appropriate speci®c anti-c-Jun, anti-Fra-1 or anti-Fra-2 antisera were included in the DNA binding reaction prior to the addition of the probe. The antisera decrease AP-1 complex formation. The degree of inhibition indicates the amount of the target protein in the complex. (D) TRE-dependent transcriptional activity peaks in the metastatic cell lines. All cell lines were transfected with the 2.5 mg of Luc reporter plasmids either containing a CollTRE consensus regulating the Luc gene (5xcollTRE-tata-luc) or not (tata-pG13Luc). Luciferase activity was determined 42 h later Elevated c-Jun, Fra-2, Fra-1, ATF-2 and AP-1 in skin tumours V Zoumpourlis et al (DNA/c-Jun or DNA/ATF-2) were supershifted by anti-c-jun and anti-ATF-2 in the malignant cell lines B9, A5 and CarB. These results are in agreement with the high levels of phosphorylated c-Jun and ATF-2 proteins in the malignant cell lines, as it was detected by Western blot analysis ( Figures 2A2 and 4A2 ).
In conclusion, all the data presented above, shows that AP-1 binding and transcriptional activity are correlated with mouse skin cell tumourigenicity. Furthermore, ATF-2 plays important role in the progression of mouse skin cancer.
ATF-2 binds on fib CRE in malignant cell lines
ATF and CREB family members bind to cyclic AMP responsive elements (CRE) on speci®c promoters, thus regulating transcription of target genes. To analyse the activity of CRE elements in keratinocyte cell lines, we performed analysis by gel retardation assay ( Figure  8A ). DNA binding activity on a typical ®bronectin CRE was signi®cantly increased in B9, A5 and CarB tumour cells (lanes 3 ± 5). Addition of an anti-ATF-2 antibody con®rmed the presence of ATF-2 in the CRE complex (lanes 6 ± 10). CRE trans-activation activity was also found to be signi®cantly increased in B9, A5 and CarB cells as compared to C5N and P1 cells, by transfecting luciferase reporter genes driven by 5XCRE ( Figure 8B ).
Discussion
In this study, we have analysed the expression and activity of members of the AP-1 transcription factor during dierent stages of mouse skin carcinogenesis. We have used immortalized and transformed keratinocyte cell lines, that have been derived from mouse epidermal tumours, to assess the role of AP-1 factors in the various stages of carcinogenesis. In nuclear cell lysates, we detected c-Jun, Fra-1, Fra-2 and ATF-2 as the major proteins induced by cellular transformation. Large amounts of phosphorylated c-Jun, Fra and ATF-2 proteins are found in squamous and spindle tumours, most probably due to Ras protein levels, which are overexpressed in these tumour cell lines (Stoler et al., 1993;  Figure 1 ). JNK kinase levels and activity were also signi®cantly elevated in tumour cell lines. Analysis of the mutant ras protein indicated a correlation between its expression levels and the tumourigenicity of the keratinocyte cell lines.
c-Jun and ATF-2 proteins are known targets of JNK kinase family members, and are phosphorylated on residues within the N-terminus trans-activation domain. The transactivation activity of ATF-2 is regulated post-translationally by phosphorylation, particularly by the JNK/SAPK and p38 groups of mitogen-activated protein kinases, after exposure to cellular stress (Van Dam et al., 1995) . ATF-2 has also Gel retardation analysis of NE from immortalized and transformed keratinocytes was performed using a jun2 TRE as a probe. The speci®c anti-c-jun and anti-ATF-2 antisera were incubated with nuclear extracts for 30 min at 48C prior to the addition of the probe. The supershifts, indicated by arrows, correspond to the jun2 TRE/c-jun or jun2 TRE/ATF-2 complexes respectively. (D) Jun2 TRE dependent transcriptional activity is elevated in the malignant cell lines. The same cell lines were transfected with 2.5 mg 5xjun2 TRE-tata-luc reporter plasmid or tatapG13luc control plasmid. The 5xjun2 TRE plasmid contains the sequence which is responsive selectively to c-jun/ATF-2 dimers Oncogene Elevated c-Jun, Fra-2, Fra-1, ATF-2 and AP-1 in skin tumours V Zoumpourlis et al been implicated in mediating a transcriptional response at the c-jun promoter. These data and our results are together in agreement with c-jun gene expression in the malignant mouse cell lines shown in Figure 2A1 and 2A2.
Since high levels of hyperphosphorylated c-Jun and ATF-2 factors as well as of active JNK kinases are detected in carcinoma cells, an important role of JNK kinases is implied during the tumour progression stages in this system. Previous studies have shown that Rasmediated transformation activates AP-1 transcription factors constitutively (Wasylyk et al., 1988) . Ectopically expressed Jun and Fos transdominant negative mutants revert ras transformed cells to a more normal phenotype (Lloyd et al., 1991) . Apparently AP-1 receives multiple Ras-mediated signals. H-ras augments c-Jun activity and stimulates phosphorylation of its activation domain, mainly on residues Ser63 and Ser73 . These results are also in agreement with previous studies by Bowden et al. (1994) in chemically induced mouse tumours. Elevated AP-1 activity in malignant compared to benign tumours has been reported . Expression of a dominant negative c-Jun mutant in malignant cells blocked AP-1 responsive genes, as well as formation of tumours upon injection of the stably transfected cells into athymic nude mice .
Analysis of expression of Jun dimerization partners in tumour cells indicated a strong correlation between malignant transformation and Jun:Fra or Jun:ATF-2 heterodimers. Jun:Fos (Fra) heterodimers are considered to be regulated by Ras-Raf-Erk pathway and Jun:ATF-2 by JNK and p38 pathways (Liu et al., 1995) . Certain Jun heterodimers can regulate a dierent set of putative target genes, which in turn contribute to speci®c aspects of the transformed cell phenotype, such as autocrine growth and anchorage independence of chicken embryo ®broblasts after transformation with dimer speci®c Jun mutants (Van Dam et al., 1998 ).
The relatively constant expression level of JunD protein in mouse keratinocyte cell lines is in agreement with the results observed in some other systems, where the c-Jun/JunD ratio increases with malignant phenotype (Pfarr et al., 1994) . Enhanced expression of JunB in squamous and not in spindle carcinoma cells was detected. It is possible that JunB sequesters other AP-1 family members like c-Jun and prevents the expression of AP-1 target genes involved in the induction of the spindle metastatic phenotype. These data con®rm that JunB diers in its biological properties from c-Jun in regulating target genes, like c-jun and collagenase (Chiu et al., 1989) .
It has been previously shown that activation of AP-1 by transforming signals can be also mediated through transcriptional activation and phosphorylation of Fra-1 and Fra-2 proteins. We con®rm that Fra proteins together with c-Jun and ATF-2 appear to be the major components of AP-1 complex in cycling keratinocytes and they are further activated in transformed cells. In squamous and spindle carcinoma cells we detected higher amounts of phosphorylated Fra-1 proteins than in cells corresponding to early stages of tumourigenesis. Phosphorylation of Fra-1 and Fra-2 has been shown to be induced by the src and ras transforming oncogenes and is mediated by members of the MAP kinase family (Murakami et al., 1997; Gruda et al., 1994) . On the other hand, fra-1 gene can be transcriptionally activated by AP-1 Figure 8 ®bCRE DNA binding and transcriptional activity are altered during mouse skin carcinogenesis. (A) In gel retardation assay equivalent amounts of NE from immortalized C5N and transformed P1, B9 and A5 cell lines were used, as well as a CRE consensus sequence of the ®bronectin promoter. The speci®c anti-c-jun and anti-ATF-2 antisera were incubated with nuclear extracts for 30 min at 48C prior to the addition of the probe. (B) Using the same conditions as described before, all the cell lines were transfected with 5xCRE ®b-tata-luc reporter plasmid or tatapG13-luc control plasmid. The 5xCRE ®b plasmid contains the sequence which is responsive selectively to CREB/ATF complexes Elevated c-Jun, Fra-2, Fra-1, ATF-2 and AP-1 in skin tumours V Zoumpourlis et al regulatory sequences located in the ®rst intron of the gene (Bergers et al., 1995) . Thus, in spindle carcinoma cells, which express high levels of mutant Ras proteins, the accumulation of high amounts of phospho-Fra1 protein may result from the transcriptional eect mediated by enhanced levels of c-Jun and Fra-2 factors and at the post-translational level by enhanced phosphorylation by MAP kinases. Furthermore, an important correlation for c-Fos protein levels in tumour progression could be con®rmed, as has been shown in other systems (Saez et al., 1995) . AP-1 complex synthesis varies depending on the mitogenic signal and cell cycle stage. In resting cells, cJun protein is expressed and AP-1 activity is mainly composed by populations of c-Jun/c-Jun homodimers or c-Jun/JunD heterodimers (Pfarr et al., 1994) . Stimulation of cells with various growth factors and activated oncogenes results in immediate transcriptional activation of the c-fos gene, which is dependent on transcription factors that are members of SRF, ets, STAT and CREB families (for reviews, Ihle, 1996; Treisman, 1994) . This results in transient overexpression of c-Fos protein and formation of cJun/cFos heterodimers just a few minutes after cell stimulation. c-fos is an immediate early gene, which is very important for rapid cell responses to stimuli, by activating a subset of target genes. In exponentially growing cells, c-Jun is generally the major component of the AP-1 complex and Fra protein levels are elevated and hyperphosphorylated, thus regulating most of the AP-1 activity, as shown in several dierent systems. In other studies, nevertheless, low levels of cfos transcript have been also reported in several types of human tumours (Zhang et al., 1997) .
ATF-2 has been reported to be phosphorylated after treatment of cells with various stress stimuli, thus regulating expression of target genes, most notably cjun gene. The composition of Jun/ATF dimers is markedly altered in adenovirus transformed cells. Most recently Jun/ATF-2 heterodimers have been shown to contribute in the appearance of growth factor independence in transformation studies of chicken embryo ®broblasts (van Dam et al., 1998) . Phosphorylation at the N-terminus modulates its intrinsic histone acetyltransferase activity (Kawasaki et al., 2000) . In this system, we detect large amounts of phosphorylated ATF-2 in tumour cell lines, which indicates an important role of ATF-2 in tumour progression. Interestingly, a faster migrating factor which is recognized by the ATF-2 speci®c antibody is present only in the spindle tumour cells and may be related to alternative spliced mutant of ATF-2. On the other hand, overexpression of dominant negative mutant of ATF-2 in A5 cells causes alters their phenotype and cell growth properties (Papassava et al., unpublished results) .
The AP-1 transcription factor can convert transient signaling events into more permanent gene expression changes. Regulation of many AP-1 target genes by Ras signaling events has been previously analysed. The cyclin D1 gene is frequently ampli®ed and overexpressed in tumours derived from epithelial cells both in human and mouse (Bianchi et al., 1993) . Members of this family are necessary for the activation of the cyclin dependent kinases (cdks), which phosphorylate the Rb protein and allow entry of the cell into S phase (Sherr, 1993) . Increased levels of mutant Ras protein appear to induce higher expression of cyclin D1 in several systems including mouse epithelial cells (Filmus et al., 1994) and NIH3T3 ®broblasts (Liu et al., 1995) . In the mouse skin system, cyclin D1 expression levels are generally higher in carcinomas than in papillomas (Crombie et al., unpublished results) and introduction of a mutant human ras construct into immortalized keratinocytes can induce expression of cyclin D1 (Haddow and Balmain, data not shown). The mechanism of cyclin D1 regulation by ras may be transcriptional, through the regulation of AP-1 transcription factors bound to the TRE site present in the cyclin D1 promoter (Albanese et al., 1995) . Another large family of AP-1 target genes includes metalloproteases and their inhibitors. We con®rm that in the very invasive spindle carcinoma cells we can detect high levels of MMP-9, which it has been shown to be regulated by AP-1 and ets factors (A Papathoma and A Pintzas, unpublished results). Thus, our results suggest that qualitative and quantitative changes in AP-1 transcription factor may provide altered cell cycle and invasive properties to cells, thus contributing to the formation of the tumorigenic phenotype.
Further analysis of the components participating in cell signalling mediated by Ras oncoproteins and JNK kinases during normal growth and cancer development of mouse skin will enable us to specify the mechanisms of signal regulated transcription in normal and transformed keratinocytes. Finally, speci®c inhibition of the same oncogenic pathways may lead to interesting prospects for tumour therapy.
Materials and methods
Cells and culture conditions
Mouse cell lines (C5N, MSCP1, B9, A5 and CarB as well as PDV57, D3, SN161 and H11) were maintained in modi®ed Eagle medium (DMEM) with 10% foetal calf serum and used for the preparation of nuclear extracts and transfections.
Preparation of nuclear and total cell extracts
For preparation of nuclear extracts, cultured cells were washed with PBS and rapidly harvested by centrifugation. Cell pellets were homogenized in a hypotonic buer (25 mM Tris-HCl pH 7.5, 5 mM KCl, 0.5 mM MgCl 2 , 0.5 mM DTT, 0.5 mM PMSF). The nuclei were pelleted at 2500 r.p.m. in a Sorvall SS34 rotor for 10 min at 48C. The pellets were washed three times with 4 ml isotonic buer (25 mM TrisHCl pH 7.5, 5 mM KCl, 0.5 mM MgCl 2 , 0.2 M sucrose, 0.5 mM DTT, 0.5 mM PMSF), and resuspended in nuclei extraction buer (25 mM Tris-HCl pH 7.5, 1 mM EDTA, 0.1% NP40, 0.5 mM DTT and 1 mM PMSF). All solutions used for preparation of nuclear extracts contained 5 mg/ml of each of the following protease inhibitors: aprotinin, pepstatin A and leupeptin. Nuclear extracts were clari®ed after centrifugation at 25 000 r.p.m. in a Beckman Ti 50 rotor for 60 min at 48C. Supernatant was removed and the extracts were stored at 7708C.
For preparation of total cell extracts cells in 9-cm dishes, cells were washed three times in ice-cold phosphate-buered saline (PBS) and lysed in 0.5 ml lysis buer (1% Triton X100; 0.5% sodium deoxycholate, 0.1% SDS; 100 mM NaCl; 50 mM Tris-HCl pH 7.4; 5 mM MgCl 2 ; 3 mM PMSF). Samples were spun for 10 min at 48C and stored at Oncogene Elevated c-Jun, Fra-2, Fra-1, ATF-2 and AP-1 in skin tumours V Zoumpourlis et al 7708C. Protein estimation was performed as described earlier (Bradford, 1976) Protein (Western blot) analysis 15 mg of nuclear proteins were electrophoresed on 10% SDSpolyacrylamide gel and transferred to nitrocellulose membrane. Blots were blocked for 2 h either in 5% BSA with TBS-0.1% Tween and 0.5 mM Na-orthovanadate when using P-speci®c antibodies or in 5% non-fat dry milk/TBS-T (TBS-T=TBS, 0.05% Tween) at room temperature for all the other antibodies. Subsequently, the membranes were typically incubated for 3 h with the corresponding primary antibodies (diluted 1 : 1000).
The following antibodies were used: anti-c-Jun, anti-c-Fos, anti-ATF-2 antibodies purchased from Santa-Cruz. antiJunB, anti-JunD, anti-Fra-1, anti-Fra-2, anti-p-c-Junser63 kindly provided by D Lallemand and M Yaniv . anti-JNK antibody was kindly provided by E Black (Black et al., 1994) . anti-p-ATF-2 antiserum was purchased from NEB. Horseradish peroxidase-conjugated secondary antibody (1 : 5000 dilution) was added and the detection of protein levels was carried out using the luminol system (Pierce).
Quanti®cation was performed by using a densitometer. For the detection of Ras proteins, we followed the combined IP and WB procedure: Total lysates were precleared with IgPAS (Protein A sepharose) and immunoprecipitated with the monoclonal antibody YA6-172 (Oncogene Science) at 1 : 1000 dilution. Immunoprecipitates brought down with IgPAS were resuspended in Western sample buer (10% b-mercaptoethanol; 2% w/v SDS; 30% w/v glycerol; 0.025% bromophenol blue with methyl green in 0.05 M Tris-HCl pH 6.8, boiled and run on 17.5% polyacrylamide gels. Proteins were blotted on to nitrocellulose membranes and incubated with pan-Ras antibody (Oncogene Science) o/n at RT.
Kinase assay
Solid-phase kinase assays were performed using glutathioneagarose GST-c-Jun (1 ± 79) as substrate. Brie¯y, nuclear extracts containing approximately 60 mg of proteins were incubated for 12 h at 48C with 5 mg of GST-c-jun (1 ± 79) protein bound to the glutathione-agarose beads to pull down JNK. Beads were recovered by centrifugation and washed two times in washing buer A (25 mM Tris pH 7.5, 100 mM KCl, 0.1% NP40, 10 mg/ml Pefablock, 2 mM orthovanadate, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 1 mM DTT and 0.5 mM PMSF) and two times with JNK buer.
Phosphorylation was performed in 30 ml JNK reaction buer containing (20 mM HEPES-NaOH pH 7.5, 10 mM MgCl 2 , 20 mM b-glycerophosphate, 1 mM DTT and 50 mM orthovanadate), 20 mM ATP and 0.5 mCi [g-32 P]-ATP at 308C for 20 min, stopped by the addition of 36 loading buer (187.5 mM Tris-HCl pH 6.8, 6% SDS, 30% glycerol, 125 mM DTT and 0.03% phenol red). P-GST-c-Jun (1 ± 79) was resolved on a 12.5% SDS-polyacrylamide gel and visualized by autoradiography.
Mobility shift assays
DNA binding reactions were carried out as follows: 2000 c.p.m. g-32 P-oligonucleotide was mixed with nuclear proteins (5 mg) in binding buer (50 mM HEPES pH 8.0, 500 mM NaCl, 0.5 M PMSF, 0.5 mg/ml BSA, 20% glycerol, 1 mM EDTA) plus 1 mm DTT and 150 mg/ml poly(dI-dC). The reaction mixture was left for 30 min at 08C. Samples were subjected to electrophoresis on 6% polyacrylamide gels for 90 min (150 V) at 208C, dried and exposed to X-ray ®lm (RX Fuji, Japan). The rabbit polyclonal antibodies to the mouse Jun, Fos and ATF-2 proteins were included in the reaction mixture and were incubated with nuclear extracts at 48C for 30 min prior to the addition of the probe.
The double stranded oligonucleotides used as probes were obtained by annealing of 5'-AGCTTGATTGAGTCAGC-CGGATC-3' and 5'-GATCCGGCTGACTCATCAAGCT-3' (collTRE, collagenase position 773 to 765), (Angel et al., 1987) 5' -AGCTAGCATTACCTCATCCC-3' and 5' -GATCGGGATGAGGTAATGCT-3' (jun2TRE, c-jun, position 7194 to 7179) and 5'-AGCTCCCGTGACGTCACC-CG-3' and 5'-GATCCGGGTGACGTCACGGG-3' (®br CRE: ®bronectin, position 7177 to 7162) (Van Dam et al., 1993) . These are labelled with g-32 P-ATP using T4 polynucleotide kinase and puri®ed on native 10% polyacrylamide gels. Values of the Y axis are arbitrary.
Plasmids, transfections and luciferase reporter assay 5XcollTREtata was kindly provided by Dr H van Dam (van Dam et al., 1998) . Mouse cell lines were transfected by the calcium phosphate method (Chen and Okayama, 1987) with 20 mg per 75-mm 2¯a sk of plasmid DNA containing 2.5 mg pSG5-lacZ (control for the eciency of transfection), 2.5 mg of reporters and completed with pSG5. 30% con¯uent cells were incubated with precipitated DNA for 18 h, washed twice with PBS and then incubated with DMEM plus 10% foetal calf serum for 24 h, scraped, freezed-thawed three times in 16Cell lysis reagent (Promega). The lysate was analysed for luciferase activity according to the manufacturers' instructions (Promega) and normalized for transfection eciency with the b-galactosidase activity. Experiments were repeated at least three times.
